Feinberg
Northwestern Medicine | Northwestern University | Faculty Profiles

News Center

  • Categories
    • Campus News
    • Disease Discoveries
    • Clinical Breakthroughs
    • Education News
    • Scientific Advances
  • Press Releases
  • Media Coverage
  • Podcasts
  • Editor’s Picks
    • COVID-19
    • Cardiology
    • Cancer
    • Neurology and Neuroscience
    • Aging and Longevity
    • Artificial Intelligence in Medicine
  • News Archives
  • About Us
    • Media Contact
    • Share Your News
    • News Feeds
    • Social Media
    • Contact Us
Menu
  • Categories
    • Campus News
    • Disease Discoveries
    • Clinical Breakthroughs
    • Education News
    • Scientific Advances
  • Press Releases
  • Media Coverage
  • Podcasts
  • Editor’s Picks
    • COVID-19
    • Cardiology
    • Cancer
    • Neurology and Neuroscience
    • Aging and Longevity
    • Artificial Intelligence in Medicine
  • News Archives
  • About Us
    • Media Contact
    • Share Your News
    • News Feeds
    • Social Media
    • Contact Us
Home » Fat Tissue May Be Key to Scleroderma’s Progression
Disease Discoveries

Fat Tissue May Be Key to Scleroderma’s Progression

By Nora DunneFeb 9, 2015
Share
Facebook Twitter Email
Loss of intradermal fat preceded fibrosis in mouse models. Above, adipocytes decrease between day 5 and 21 after bleomycin-induced scleroderma in mice.

Northwestern Medicine scientists have discovered that scar-forming cells in scleroderma come from fat tissue within layers of the skin, a new cellular origin that could be a key to developing treatments for the incurable disease in the future.

Scleroderma, also called systemic sclerosis, is a rare autoimmune connective tissue disorder in which the skin thickens and hardens, forming scar-like buildup, a process called fibrosis. Until now, scientists have not known the mechanisms responsible for tissue fibrosis.

In a new study published in Arthritis & Rheumatology, first author Roberta Goncalves-Marangoni, MD, PhD, research assistant professor in Medicine-Rheumatology, and colleagues examined skin biopsies from patients with scleroderma and used genetically engineered mice to show that fat within the skin called adipose tissue is an important cellular source of scarring in the disease.

“This was a surprising, but potentially important discovery,” said senior author John Varga, MD, John and Nancy Hughes Distinguished Professor of Rheumatology in Medicine-Rheumatology and Dermatology. “This is the first study to associate fat cells with fibrosis. This has implications for understanding and treating scleroderma, as well as more common forms of fibrosis such as liver cirrhosis, bone marrow fibrosis and possibly cancer.”

Fat tissue residing within the skin, unlike visceral fat stored in the abdomen, is not related to obesity. Instead, it’s thought to be involved in heat insulation, mechanical functions and energy storage. The study found that adipocytes – the cells that store energy as fat in the skin – disappear from the skin  when mice develop scleroderma.

John Varga, MD, John and Nancy Hughes Distinguished Professor of Rheumatology in Medicine-Rheumatology and Dermatology, was senior author of the study that showed scar-forming cells in scleroderma originate in fat tissue within the skin.

“We show that the fat cells in the skin become activated and change into scar-forming cells. They migrate into the upper layers of the skin where they cause scarring,” Dr. Varga said.

With further research, this pathway may be a target for future scleroderma therapies.

“We are now exploring ways to prevent this process and the scarring from occurring. We hope to develop drugs or use existing drugs to slow down transformation of fat cells into scar-forming cells,” said Dr. Varga, who is director of the Northwestern Scleroderma Program and a member of the Robert H. Lurie Comprehensive Cancer Center of Northwestern University.

Additional Feinberg authors involved in this study include Benjamin Korman, MD, ’12, ’14 GME, instructor in Medicine-Rheumatology, Jun Wei, PhD, research assistant professor in Medicine-Rheumatology, Warren Tourtellotte, MD, PhD, associate professor in Pathology and Neurology, and Lauren Graham, MD, PhD, resident in Dermatology. Scientists from the University of Texas Southwestern Medical School in Dallas and Dartmouth Medical College also participated in this work.

This study was supported by National Institutes of Health (NIH) grants AR-42309, OD-010945, CA-060553 and P30AR061271 and the National Institute of Arthritis and Musculoskeletal and Skin Diseases.

Dermatology Immunology Research
Share. Facebook Twitter Email

Related Posts

Mar 29, 2023

Adolescent Sexual Health Program Receives Funding for Social Marketing Campaign

Mar 29, 2023

The Future of IgE-Mediated Allergy Research and Treatments

Mar 29, 2023

Investigating Protein’s Role in Hearing Loss

Mar 27, 2023

Comments are closed.

Latest News

Adolescent Sexual Health Program Receives Funding for Social Marketing Campaign

Mar 29, 2023

The Future of IgE-Mediated Allergy Research and Treatments

Mar 29, 2023

Weintraub Appointed to Illinois Supreme Court Commission on Elder Law

Mar 28, 2023

Investigating Protein’s Role in Hearing Loss

Mar 27, 2023

Sex-Specific Mechanisms for Major Depressive Disorder Identified in Response to Dysregulated Stress Hormones

Mar 23, 2023
  • News Center Home
  • Categories
  • Press Release
  • Media Coverage
  • Editor’s Picks
  • News Archives
  • About Us
Flickr Photos
20230317_NM651
20230317_NM610
20230317_NM569
20230317_NM537
20230317_NM331
20230317_NM323
20230317_NM316
20230317_NM336
20230317_NM626
20230317_NM662
20230317_NM655
20230317_NM642

Northwestern University logo

Northwestern University Feinberg School of Medicine

RSS Facebook Twitter LinkedIn Flickr YouTube Instagram
Copyright © 2023 Northwestern University
  • Contact Northwestern University
  • Disclaimer
  • Campus Emergency Information
  • Policy Statements

Type above and press Enter to search. Press Esc to cancel.